CD8A and lung carcinoma: MRX0518 is a strain of E. gallinarum and monotherapy with MRX0518 was able to reduce tumour size in syngeneic mouse models of breast and lung carcinoma associated with an increase in the CD8+ T-cell: Treg ratio.